Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects

被引：0
|
作者：
Christa Claes
Ralf René Reinert
Johann-Matthias Graf von der Schulenburg
机构：
[1] Leibniz University of Hannover,Centre for Health Economics and Health System Research
[2] University Hospital RWTH Aachen,Institute of Medical Microbiology, National Reference Centre for Streptococci
来源：
The European Journal of Health Economics | 2009年 / 10卷
关键词：
Pneumococcal conjugate vaccine (PCV7); Herd immunity; Pneumococcal disease; Germany;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 38
页数：13
相关论文
共 50 条
  • [1] Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects
    Claes, Christa
    Reinert, Ralf Rene
    von der Schulenburg, Johann-Matthias Graf
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2009, 10 (01): : 25 - 38
  • [2] Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects
    Adam Lloyd
    Nishma Patel
    David A. Scott
    Claus Runge
    Christa Claes
    Markus Rose
    The European Journal of Health Economics, 2008, 9 : 7 - 15
  • [3] Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects
    Lloyd, Adam
    Patel, Nishma
    Scott, David A.
    Runge, Claus
    Claes, Christa
    Rose, Markus
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 9 (01): : 7 - 15
  • [4] Cost effectiveness of heptavalent pneumococcal conjugate vaccine in populations of high risk in Colombia
    Alvis Guzman, Nelson
    De la Hoz, Fernando
    COLOMBIA MEDICA, 2010, 41 (04): : 315 - 322
  • [5] COST-EFFECTIVENESS OF HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV-7) IN MEXICO
    Carlos, F.
    Mercado, G.
    Aguirre, A.
    Vargas, A.
    Bierschwale, H.
    VALUE IN HEALTH, 2009, 12 (07) : A420 - A420
  • [6] Cost effectiveness of adding 7-valent pneumococcal conjugate vaccine to a childhood vaccination - Impact of herd immunity
    Kristiansen, JS
    Wisloff, TF
    VALUE IN HEALTH, 2006, 9 (03) : A154 - A155
  • [7] Herd immunity and pneumococcal conjugate vaccine: A quantitative model
    Haber, Michael
    Barskey, Albert
    Baughman, Wendy
    Barker, Lawrence
    Whitney, Cynthia G.
    Shaw, Kate M.
    Orenstein, Walter
    Stephens, David S.
    VACCINE, 2007, 25 (29) : 5390 - 5398
  • [8] The impact of indirect (Herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine
    Isaacman, Daniel J.
    Strutton, David R.
    Kalpas, Edward A.
    Horowicz-Mehler, Nathalie
    Stern, Lee S.
    Casciano, Roman
    Ciuryla, Vincent
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 341 - 357
  • [9] Clinical and economic impact of herd immunity associated with heptavalent pneumococcal conjugate vaccination in Canada
    Ford, MW
    Wang, ECY
    Ciuryla, V
    VALUE IN HEALTH, 2004, 7 (03) : 357 - 357
  • [10] Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine
    Payeras, Antoni
    Villoslada, Aroa
    Garau, Margarita
    Borras, Maria
    Pareja, Antonio
    Beingolea, David
    Garcia-Gasalla, Mercedes
    del Carmen Gallegos, M.
    Jose Alonso-Villaverde, Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (04): : 250 - 256
12345